Words of Wisdom
2008
November
Volume 52 -11 November 2008
Re: The Metabolites Citrate, Myo-Inositol, and Spermine Are Potential Age-Independent Markers of Prostate Cancer in Human Expressed Prostatic Secretions
Jung K
Re: A 5-Year Follow-Up Study of Asymptomatic Men with Testicular Microlithiasis
Albrecht W
Re: Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma
Bedke J, Pelzer A
Re: Use of Androgen Deprivation Therapy for Metastatic Prostate Cancer in Older Men
Daneshmand S
Re: Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III Study
Tombal B.
Re: Effects of Pathologic Stage on the Learning Curve for Radical Prostatectomy: Evidence That Recurrence in Organ-Confined Cancer Is Largely Related to Inadequate Surgical Technique
October
Volume 52-10 October 2008
Re: Prostate-Cancer Mortality in the USA and UK in 1975–2004: An Ecological Study
Collin SM, Martin RM, Metcalfe C, et al
Re: Cumulative Association of Five Genetic Variants with Prostate Cancer
Zheng SL, Sun J, Wiklund F, et al
Re: Prostate Cancer Stem Cells: A New Target for Therapy
Maitland NJ, Collins AT
Re: Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer in Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)
Wolters T, Roobol MJ, Bangma CH, Schroder FHRe:
The Efficacy and Safety of Udenafil, a New Selective Phosphodiesterase Type 5 Inhibitor, in Patients with Erectile Dysfunction
Paick J-S, Kim SW, Yang DY et al.
Re: Bevacizumab plus Interferon alfa-2a for Treatment of Metastatic Renal Cell Carcinoma: A Randomised, Double-Blind Phase III Trial
Escudier B, Pluzanska A, Koralewski P, et al, for the AVOREN Trial investigators
Bangma CH, Wildhagen MF
September
Volume 52-9 September 2008
Re: Photoselective Potassium Titanyl Phosphate (KTP) Laser Vaporization Versus Transurethral Resection of the Prostate for Prostates Larger Than
70 mL: A Short-Term Prospective Randomized Trial
Horasanli K, Silay MS, Altay B, et al.
Re: A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences
Berrum-Svennung I, Gransfors T, Jahnson S et al.
Re: Saturation Prostate Needle Biopsy and Prostate Cancer Detection at Initial and Repeat Evaluation
Pepe P, Aragona F
Re: Lymph Node Density Is Superior to TNM Nodal Status in Predicting Disease-Specific Survival
After Radical Cystectomy for Bladder Cancer: Analysis of Pooled Data From MDACC and MSKCC
Kassouf W, Agarwal PK, Herr HW, et al.
August
Volume 52-8 August 2008
Re: Cumulative Association of Five Genetic Variants with Prostate Cancer
Zheng SL, Sun J, Wiklund F, et al
Re: Design and Endpoints of Clinical Trials in Patients with Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Scher HJ, Halabi S, Tannock I, et al
Re: Lower Urinary Tract Symptoms in Dementia with Lewy Bodies, Parkinson Disease, and Alzheimer Disease
Ransmayr GN, Holliger S, Schletterer K, et al
Re: Is Kidney Surgery Going to be Minimally Invasive in All Cases?
Sulser T
Re: Medical Therapy to Facilitate Urinary Stone Passage: A Meta-analysis
Hollingsworth JM, Rogers M,Kaufman S,et al
Re: Reassessing the Value of Varicocelectomy as a Treatment for Male Subfertility with a New Meta-Analysis
Marmar JL, Agarwal A, Prabakaran S,
JuneVolume 52-6 June 2008Re: Defining Optimal Therapy for Muscle-Invasive Bladder CancerHerr HW, Dotan Z, Donat SM, Bajorin DFRe: Are Doctors Examining Prostates In University Hospital?Lim CH, Quinlan DMRe: Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular MortalityTsai H, Damico A, Sadetsky N, Carrol PRe: Stimulation of Prostate Cancer Cellular Proliferation and Invasion by the Androgen Receptor Co-activator ARA70Peng J, Li CX, Chen F et alRe: Cumulative Association of Five Genetic Variants with Prostate CancerZheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G,Adami HO, Hsu FC, Zhu Y et alRe: Effect of a1-Adrenoreceptor Antagonist Exposure on Prostate Cancer Incidence: An Observational Cohort StudyHarris AM, Warner BW, Wilson JM et al
MayVolume 52-5 May 2008Re: Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men: A Randomized ControlledTrialEmmelot-Vonk MH, Verhaar HJJ, Pour HRN, Aleman A, Lock TMTW, Bosch JLHR, Grobbee DE, van der Schouw YT Re: Androgen Withdrawal in Patients Reduces Prostate Cancer Hypoxia: Implications for Disease Progression and Radiation ResponseMilosevic M, Chung P, Parker C, Bristow R, Toi A, Panzarella T, Warde P, Catton C, Menard C, Bayley A, Gospodarowicz M, Hill RRe: Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell CarcinomaChoueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski RM, Escudier BRe: Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular CancerStephenson AJ, Bosl GJ, Motzer RJ, Barjorin DF, Stati JP, Sheinfeld J AprilVolume 52-4 April 2008Re: Prognostic Relevance of Capsular Involvement and Collecting System Invasion in Stage I and II Renal Cell CarcinomaKlatte T, Chung JS, Leppert JT, Lam JS, Pantuck AJ,Figlin RA, Belldegrun ASRe: Prostate Specific Antigen Velocity in Men with Total Prostate Specific Antigen Less than 4 ng/mlLoeb S, Roehl KA, Nadler RB, Yu X, Catalona WJRe: Prostate Specific Antigen Velocity in Men with Total Prostate Specific Antigen Less than 4 ng/mlLoeb S, Roehl KA, Nadler RB, Yu X, Catalona WJRe: Identification of Patients with Prostate Cancer Who Benefit from Immediate Postoperative Radiotherapy: EORTC 22911Van der Kwast TH, Bolla M, Van Poppel H, Van Cangh P, Vekemans K, Da Pozzo L, Bosset JF, Kurth KH, Schro¨ der FH, Collette L; EORTC 22911Re: A New Technique of Vaginal Reconstruction with the Deep Inferior Epigastric Perforator Flap: A Preliminary ReportWang X, Qiao Q, Burd A, Liu Z, Zao R, Song K, Feng R, Zeng A, Zhao Y
MarchVolume 52-3 March 2008Re: Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True PrevalenceRoemeling S, Schröder FRe: Identification of Patients with Prostate Cancer Who Benefit from Immediate Postoperative Radiotherapy:EORTC 22911Graefen M.Re: Use of Combined Apoptosis Biomarkers for Prediction of Bladder Cancer Recurrence and Mortality after Radical CystectomySagalowsky A.Re: Limited Tissue Penetration of Taxanes: A Mechanism for Resistance in Solid TumorsBastian P.
February
Volume 52-2 February 2008
Re: Identification of Patients with Prostate Cancer Who Benefit from Immediate Postoperative Radiotherapy: EORTC 22911
Mongiat-Artus P
Re: Radial Distance of Extraprostatic Extension Measured by Ocular Micrometer is an Independent Predictor of Prostate-Specific Antigen Recurrence. A New Proposal for the Substaging of pT3a Prostate Cancer
Montironi R
Re: Prognostic Risk Stratification and Clinical Outcomes in Patients Undergoing Surgical Treatment for Renal Cell Carcinoma with Vascular Tumor Thrombus
Bastian PJ
Re: Video Endoscopic Lymphadenectomy: A New Minimally Invasive Procedure for Radical Management of Inguinal Nodes in Patients with Penile Squamous Cell Carcinoma
Carmignani G
January
Volume 52-1 January 2008
Re: Cystectomy for Transitional Cell Carcinoma of the Bladder: Results of a Surgery Only Series in the Neobladder Era
Albers P
Re: The Role of Squamous Differentiation in Patients with Transitional Cell Carcinoma of the Bladder Treated with Radical Cystectomy
Pavone-Macaluso M
Re: EPCA-2: A Highly Specific Serum Marker for Prostate Cancer
Katz MD, Kibel AS
Re: Duplication of the Fusion of TMPRSS2 to ERG Sequences Identifies Fatal Human Prostate Cancer
2007
Volume 52-1 December 2007
Re: Efficacy of Botulinum Toxin-A for Treating Idiopathic Detrusor Overactivity: Results from a Single Center, Randomized, Double-Blind, Placebo Controlled Trial
Kessler T
Re: Burch Colposuspension versus Fascial Sling to Reduce Urinary Stress Incontinence
Daneshgari F
Re: High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors
Gasser T
Re: The Relationship between the Extent of Surgical Margin Positivity and Prostate-Specific Antigen Recurrence in Radical Prostatectomy Specimens
Algaba F
Re: Lymphatic Invasion is a Prognostic Factor for Bladder Cancer Treated with Radical Cystectomy
Colombo R
Re: Radical Cystectomy with Extended Lymphadenectomy: Evaluating Separate Package versus en bloc Submission for Node Positive Bladder Cases
Grossman HB
Volume 52-4 November 2007
Re: Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005
Kattan MW
Re: Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers
Boormans J
Re: A New Postoperative Predictor of Time to Urinary Continence after Laparoscopic Radical Prostatectomy: The Urine Loss Ratio
Romics I
Re: Adjuvant Weekly Docetaxel for Patients with High Risk Prostate Cancer after Radical Prostatectomy: A Multi-institutional Pilot Study
Raghavan D
Re: Serum Bone Turnover Markers (PINP and ICTP) for the Early Detection of Bone Metastases in Patients With Prostate Cancer: A Longitudinal Approach
Sciarra A
Volume 52-1 October 2007
Re: Statin Drugs and Risk of Advanced Prostate Cancer (PC)
Schröder FH
Re: Upsizing of Inflatable Penile Implant Cylinders in Patients with Corporal Fibrosis
Ralph D
Re: Effects of a New Functional-Sexological Treatment for Premature Ejaculation
Hartmann UH
Re: Preoperative Lymphoscintigraphy and Dynamic Sentinel Node Biopsy for Staging Penile Cancer: Results with Pathological Correlation
Horenblas S
Volume 52-3 September 2007
Re: Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism
Lue T.F., Bella A.J.
Re: Detection of Circulating Urothelial Cancer Cells in the Blood Using the CellSearch System
Morales A.
Re: Genome-wide Association Study of Prostate Cancer Identifies a Second Risk Locus at 8q24
Kiemeney L.A.
Re: Prostate-Specific Antigen (PSA) and PSA Velocity for Prostate Cancer Detection in Men Aged <50 Years
Schröder F.H., Roobol M.J.
Re: Detection of Life-Threatening Prostate Cancer with Prostate-Specific Antigen Velocity during a Window of Curability
Schröder F.J.
Volume 52-2 August 2007
Re: Male Circumcision for HIV Prevention in Young Men in Kisumu, Kenya: A Randomised Controlled Trial
Weidner W.
Re: Persistent Motile Sperm after Ligation Band Vasectomy
Lamb D.J., Alukal J.P.
Re: Age Adjusted Prostate Specific Antigen and Prostate Specific Antigen Velocity Cut Points in Prostate Cancer Screening
Taneja S.S.
Re: Extended 21-Sample Needle Biopsy Protocol for Diagnosis of Prostate Cancer in 1000 Consecutive Patients
Andriole G.L.
Re: Detection of Occult Lymph Node Metastases in Locally Advanced Node-Negative Prostate Cancer
Thalmann G.N.
Re: Bicalutamide 150mg Plus Standard Care vs Standard Care Alone for Early Prostate Cancer
Jocham D.
Volume 52-1 July 2007
Re: Sorafenib in Advanced Clear-Cell Renal Cell Carcinoma
Karakiewicz P.I., Hutterer G.
Re: Cytoreductive Nephrectomy in the Elderly Patient: The M.D. Anderson Cancer Center Experience
Karakiewicz P.I., Walz J.
Re: Postoperative Nomogram Predicting Risk of Recurrence after Radical Cystectomy for Bladder Cancer
Ehdaie B., Theodorescu D.
Re: Erectile Function after Prostate Brachytherapy
Incrocci L., van der Wielen G.J.
Re: Complications of Porcine Small Intestinal Submucosa (SIS) Graft for Peyronie's disease (PD)
Kadioglu A.
Re: Effect of Testosterone Replacement Therapy on Prostate Tissue in Men with Late-Onset Hypogonadism: A Randomized Controlled Trial
Khera M., Lipshultz M.I.
Volume 51-6 June 2007
Re: Survival Associated with Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Barry M.J.
Re: Survival of Men with Clinically Localized Prostate Cancer Treated with Prostatectomy, Brachytherapy, or No Definitive Treatment: Impact of Age at Diagnosis
Klein E.A., Abouassaly R.
Re: The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients with T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial
Malmström P.U.
Re: Tolterodine and Tamsulosin for Treatment of Men with Lower Urinary Tract Symptoms and Overactive Bladder
Gerber G.
Volume 51-5 May 2007
Re: Long-term Prediction of Prostate Cancer up to 25 Years before Diagnosis of Prostate Cancer Using Prostate Kallikreins Measured at Age 44 to 50 Years
Bangma C
Re: The Age Related Decrease in Testosterone is Significantly Exacerbated in Obese Men with the Metabolic Syndrome. What are the Implications for the Relatively High Incidence of Erectile Dysfunction Observed in These Men?
Dohle G.R.
Re: Longitudinal PSA Changes in Men with and without Prostate Cancer: Assessment of Prostate Cancer Risk
Roobol M.J.
Re: Five-year Follow-up of Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy for Treatment of Prostate Cancer
Schenk-Braat E.A.M.
Re: Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Schröder F.
Re: Sunitinib versus Interferon alfa in Metastatic Renal-Cell Carcinoma
Verhagen P.C.M.S.
Re: Aluminum Citrate Inhibits Cytotoxicity and Aggregation of Oxalate Crystals
Verkoelen C.
Volume 51-4 April 2007
Re: Reconstruction of the Male Urethra in Strictures
Mundy A.R.
Re: Should We Screen for Bladder Cancer in a High-Risk Population? A Cost Per Life-Year Saved Analysis
Messing E
Re: Nomograms Provide Improved Accuracy for Predicting Survival after Radical Cystectomy
Black P, Dinney C
Re: Nephroureterectomy for Treating Upper Urinary Tract Transitional Cell Carcinoma. Time to Change the Treatment Paradigm?
Kirkali Z
Re: Poorly Differentiated Prostate Cancer Treated with Radical Prostatectomy: Long-term Outcome and Incidence of Pathological Downgrading
Bastian P
Volume 51-3 March 2007
Re: Pathologic Guidelines for Orthotopic Urinary Diversion in Women with Bladder Cancer: A Review of the Literature
Stenzl A
Re: Reevaluating Occult Stress Incontinence
Twiss C, Triaca V, Raz S
Re: A Molecular Correlate to the Gleason Grading System for Prostate Adenocarcinoma
Jung K
Re: Metastatic Prostate Cancer—Does Treatment of the Primary Tumor Matter?
Smith J, Bray W
Re: Vaccination of Hormone-Refractory Prostate Cancer Patients with Peptide Cocktail-Loaded Dendritic Cells: Results of a Phase 1 Clinical Trial
Schmid H.P.
Re: Primary T1G3 Bladder Cancer: Organ Preserving Approach or Immediate Cystectomy?
Dalbagni G
Volume 51-2 February 2007
Re: Twenty Years Experience With an Ileal Orthotopic Low Pressure Bladder Substitute—Lessons to be Learned
Gasser T
Re: Abdominal Sacrocolpopexy With Burch Colposuspension to Reduce Urinary Stress Incontinence
Steers W
Re: Incidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United States
Lotan Y
Re: Poorly Differentiated Prostate Cancer Treated With Radical Prostatectomy: Long-Term Outcome and Incidence of Pathologic Downgrading
Carini M
Re: Contribution of 11C-Choline Positron Emission Tomography/Computerized Tomography to Preoperative Staging of Advanced Transitional Cell Carcinoma
Steinberg G
Re: Superficial (pT2a) and Deep (pT2b) Muscle Invasion in Pathological Staging of Bladder Cancer Following Radical Cystectomy
Jakse G
Volume 51-1 January 2007
Re: Assessment of the Impact of Sildenafil Citrate on Lower Urinary Tract Symptoms in Men with Erectile Dysfunction
Hatzimouratidis K
Re: Alfuzosin 10mg Once Daily Prevents Overall Clinical Progression of Benign Prostatic Hyperplasia but not Acute Urinary Retention: Results of a 2-Year Placebo-Controlled Study,
Madersbacher J
Re: Nocturnal Tumescence: A Parameter for Postoperative Erectile Integrity After Nerve Sparing Radical Prostatectomy
Mulhall J
Re: Prediction of Postoperative Sexual Function After Nerve Sparing Radical Retropubic Prostatectomy
Salonia A
Re: Diabetes Mellitus and Hypertension Associated With Shock Wave Lithotripsy of Renal and Proximal Ureteral Stones at 19 Years of Followup
Whitfield H.N.
Re: Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence
Ficarra V
2006
